Skip to main content
. Author manuscript; available in PMC: 2020 Nov 1.
Published in final edited form as: Drug Alcohol Depend. 2019 Sep 3;204:107537. doi: 10.1016/j.drugalcdep.2019.06.039

Table 1.

Fatal opioid overdose standardized mortality ratios (SMR) and population attributable fractions (PAF) associated with exposure to opioid prescription and critical encounter touchpoints in past 12 months, Massachusetts, 2014.

Touchpoint Person years (%)a Opioid deaths (%)a Opioid death incidence
rate per 100,000 person
years
SMR (95% CI)b PAF (95% CI)b
All residentsc 6,717,390 (100%) 1315 (100%) 19.6 N/A N/A
Any touchpoint 183,089 (2.7%) 681 (51.8%) 372 35.2 (32.6, 37.9) 0.50 (0.47, 0.53)
Any opioid prescription touchpointd 148,535 (2.2%) 269 (20.5%) 181 12.6 (11.1, 14.1) 0.19 (0.17, 0.21)
High dosage 36,330 (0.5%) 100 (7.6%) 275 15.1 (12.1, 18.0) 0.07 (0.06, 0.09)
Benzodiazepine co-prescribing 50,130 (0.7%) 132 (10.0%) 263 18.0 (14.9, 21.1) 0.09 (0.08, 0.11)
Multiple prescribers 95,656 (1.4%) 165 (12.5%) 172 10.5 (8.9, 12.1) 0.11 (0.10, 0.13)
Multiple pharmacies 39,890 (0.6%) 114 (8.7%) 286 14.4 (11.8, 17.1) 0.08 (0.07, 0.10)
Any critical encounter touchpoint 38,948 (0.6%) 491 (37.3%) 1261 68.4 (62.4, 74.5) 0.37 (0.34, 0.39)
Opioid detoxification 16,541 (0.2%) 259 (19.7%) 1,844 66.1 (58.0, 74.1) 0.19 (0.17, 0.22)
Nonfatal opioid overdosee 9,208 (0.1%) 223 (17.0%) 2,422 111 (96.7, 126) 0.17 (0.15, 0.19)
Injection-related infectionf 5,752 (0.1%) 81 (6.4%) 1,408 54.1 (42.43 65.8) 0.06 (0.05, 0.07)
Release from incarceration 14,686 (0.2%) 126 (9.6%) 858 30.0 (24.8, 35.3) 0.09 (0.08, 0.11)
a

Percentages are relative to all residents; the categories identified are not mutually exclusive and column percentages do not add to 100%.

b

Standardized for age group and sex.

c

Data for Massachusetts residents ages 11 years or older in 2014.

d

Opioid prescription touchpoints identified as: three or more months in past year with more than 100 mg average daily morphine equivalents or opioid and benzodiazepine co-prescribing, or one or more quarters in past year with three or more different opioid prescribers or pharmacies dispensing opioids.

e

Nonfatal opioid overdose identified from ambulance, emergency department, outpatient observation, or inpatient discharge for opioid overdose without death in subsequent 7 days.

f

Emergency department, outpatient observation, or inpatient discharge for cellulitis, abscess, osteomyelitis, or endocarditis likely due to injection based on past 12-month history of diagnosis of opioid use disorder or hepatitis C virus.